Veerhealth Care Ltd — Important, 25-02-2026: Company Update

Veerhealth Care submitted an investor presentation detailing significant developments. The company secured USFDA registration and approval for Drug (OTC) products, enabling exports to the U.S. This positions it as a small-cap firm with a USFDA-cleared plant. The presentation also highlighted Ayuveer's expanded e-commerce presence and the new VEER PLAST division for backward integration. For the latest quarter, revenue from operations was 7.26 Cr, with total comprehensive income at 0.40 Cr. The company projects stronger future results, aiming for global leadership with expanded facilities and a major FMCG partnership, reinforcing its "Local to Global" strategy.